Induction of protective immunity in a syrian hamster model against a cytopathogenic strain of andes virus

Journal of Medical Virology

Volumn 84, Issue 1, 2012, Pages 87-95

  Martinez, Valeria Paula ^a   Padula, Paula Julieta ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Hantavirus pulmonary syndrome; Mesocricetus auratus; Vaccine candidate

Indexed keywords

ANDES VIRUS RECOMBINANT NUCLEOCAPSID PROTEIN VACCINE; IMMUNOGLOBULIN G; NUCLEOCAPSID PROTEIN; SEOV RECOMBINANT NUCLEOCAPSID PROTEIN VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANDES VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARGENTINA; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EFFICACY; ESCHERICHIA COLI; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; IMMUNITY; MALE; NONHUMAN; PROTEIN EXPRESSION; SYRIAN HAMSTER; VACCINATION; VERO CELL; VIRUS NEUTRALIZATION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; CRICETINAE; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; HANTAVIRUS; HANTAVIRUS INFECTIONS; MALE; MESOCRICETUS; SEOUL VIRUS; SURVIVAL ANALYSIS; VERO CELLS; VIRAL PLAQUE ASSAY;

ANDES VIRUS; ANIMALIA; CRICETINAE; HANTAVIRUS; MESOCRICETUS AURATUS; SEOUL VIRUS;

EID: 81355138388     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22228     Document Type: Article

References (39)

1. Bharadwaj M, Lyons CR, Wortman IA, Hjelle B. 1999. Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 17: 2836-2843.
2. Bharadwaj M, Mirowsky K, Ye C, Botten J, Masten B, Yee J, Lyons CR, Hjelle B. 2002. Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus). J Gen Virol 83: 1745-1751.
3. Chu YK, Jennings GB, Schmaljohn CS. 1995. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J Virol 69: 6417-6423.
4. Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW. 2003. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 77: 9894-9905.
5. Dargeviciute A, Brus Sjolander K, Sasnauskas K, Kruger DH, Meisel H, Ulrich R, Lundkvist A. 2002. Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine 20: 3523-3531.
6. de Carvalho Nicacio C, Gonzalez Della Valle M, Padula P, Bjorling E, Plyusnin A, Lundkvist A. 2002. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. J Virol 76: 6669-6677.
7. Eyzaguirre EJ, Milazzo ML, Koster FT, Fulhorst CF. 2008. Choclo virus infection in the Syrian golden hamster. Am J Trop Med Hyg 78: 669-674.
8. Ferres M, Vial P, Marco C, Yanez L, Godoy P, Castillo C, Hjelle B, Delgado I, Lee SJ, Mertz GJ. 2007. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile. J Infect Dis 195: 1563-1571.
9. Grossblatt N, editor. 1996. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Research Council.
10. Hardestam J, Simon M, Hedlund KO, Vaheri A, Klingstrom J, Lundkvist A. 2007. Ex vivo stability of the rodent-borne Hantaan virus in comparison to that of arthropod-borne members of the Bunyaviridae family. Appl Environ Microbiol 73: 2547-2551.
11. Hooper JW, Larsen T, Custer DM, Schmaljohn CS. 2001. A lethal disease model for hantavirus pulmonary syndrome. Virology 289: 6-14.
12. Johnson AM, Bowen MD, Ksiazek TG, Williams RJ, Bryan RT, Mills JN, Peters CJ, Nichol ST. 1997. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 238: 115-127.
13. Johnson AM, de Souza LT, Ferreira IB, Pereira LE, Ksiazek TG, Rollin PE, Peters CJ, Nichol ST. 1999. Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol 59: 527-535.
14. Khaiboullina SF, Morzunov SP, St Jeor SC. 2005. Hantaviruses: Molecular biology, evolution and pathogenesis. Curr Mol Med 5: 773-790.
15. Klingstrom J, Maljkovic I, Zuber B, Rollman E, Kjerrstrom A, Lundkvist A. 2004. Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge. Vaccine 22: 4029-4034.
16. Koletzki D, Lundkvist A, Sjolander KB, Gelderblom HR, Niedrig M, Meisel H, Kruger DH, Ulrich R. 2000. Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles. Virology 276: 364-375.
17. Lopez N, Padula P, Rossi C, Lazaro ME, Franze-Fernandez MT. 1996. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220: 223-226.
18. Lundkvist A, Kallio-Kokko H, Sjolander KB, Lankinen H, Niklasson B, Vaheri A, Vapalahti O. 1996. Characterization of Puumala virus nucleocapsid protein: Identification of B-cell epitopes and domains involved in protective immunity. Virology 216: 397-406.
19. Machado AM, Figeiredo GG, Sabino GSJ, Machado AR, Figueiredo LT. Araraquara Hantavirus: First isolation in cell culture from infected rodent in Brazil 2010; Athenas, Greece. Abstract Book of VIII International Conference on HFRS, HPS and Hantavirus, p 185.
20. Manigold T, Mori A, Graumann R, Llop E, Simon V, Ferres M, Valdivieso F, Castillo C, Hjelle B, Vial P. 2010. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog 6: e1000779.
21. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, Padula PJ. 2005. Person-to-person transmission of Andes virus. Emerg Infect Dis 11: 1848-1853.
22. Martinez VP, Bellomo CM, Cacace ML, Suarez P, Bogni L, Padula PJ. 2010. Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerg Infect Dis 16: 1853-1860.
23. McElroy AK, Smith JM, Hooper JW, Schmaljohn CS. 2004. Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters. Virology 326: 130-139.
24. Padula PJ, Edelstein A, Miguel SD, Lopez NM, Rossi CM, Rabinovich RD. 1998. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus. Virology 241: 323-330.
25. Padula PJ, Colavecchia SB, Martinez VP, Gonzalez Della, Valle MO, Edelstein A, Miguel SD, Russi J, Riquelme JM, Colucci N, Almiron M, Rabinovich RD. 2000a. Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America. J Clin Microbiol 38: 3029-3035.
26. Padula PJ, Rossi CM, Della Valle MO, Martinez PV, Colavecchia SB, Edelstein A, Miguel SD, Rabinovich RD, Segura EL. 2000b. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol 49: 149-155.
27. Padula PJ, Sanchez AJ, Edelstein A, Nichol ST. 2002. Complete nucleotide sequence of the M RNA segment of Andes virus and analysis of the variability of the termini of the virus S, M and L RNA segments. J Gen Virol 83: 2117-2122.
28. Padula PJ, Martinez VP, Cueto GR, Cavia R, Suárez OV. 2010. Partial genetic characterization of Seoul hantavirus in rats of Buenos Aires city and generation of a Seoul recombinant nucleoprotein antigen. Rev Pan-Amazonian J Health 1: 97-103.
29. Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, St Jeor S, Feldmann H, Johnson DC. 2009. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol 83: 7285-7295.
30. Schmaljohn C. 2009. Vaccines for hantaviruses. Vaccine 27: D61-D64.
31. Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM. 1990. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 64: 3162-3170.
32. Summers PL, McClain DJ. 1999. In: Chapter VII: Virus detection and identification with serological tests. Plaque assay and plaque reduction neutralization test (PRNT), Lee HW, Calisher C, Schmaljohn C, editors. Manual of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Seoul: WHO Collaborating Center for Virus Reference and Research (Hantaviruses). Asan Institute for Life Sciences, pp 92-98.
33. Takita-Sonoda Y, Fujii H, Mifune K, Ito Y, Hiraga M, Nishizono A, Mannen K, Minamoto N. 1993. Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection. Arch Virol 132: 51-65.
34. Tischler ND, Galeno H, Rosemblatt M, Valenzuela PD. 2005. Human and rodent humoral immune responses to Andes virus structural proteins. Virology 334: 319-326.
35. Ulrich R, Lundkvist A, Meisel H, Koletzki D, Sjolander KB, Gelderblom HR, Borisova G, Schnitzler P, Darai G, Kruger DH. 1998. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine 16: 272-280.
36. Valdivieso F, Vial P, Ferres M, Ye C, Goade D, Cuiza A, Hjelle B. 2006. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerg Infect Dis 12: 166-168.
37. Wahl-Jensen V, Chapman J, Asher L, Fisher R, Zimmerman M, Larsen T, Hooper JW. 2007. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J Virol 81: 7449-7462.
38. Yoshimatsu K, Yoo YC, Yoshida R, Ishihara C, Azuma I, Arikawa J. 1993. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch Virol 130: 365-376.
39. Yoshimatsu K, Arikawa J, Tamura M, Yoshida R, Lundkvist A, Niklasson B, Kariwa H, Azuma I. 1996. Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies. J Gen Virol 77: 695-704.